Page last updated: 2024-09-05

sorafenib and daidzein

sorafenib has been researched along with daidzein in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(daidzein)
Trials
(daidzein)
Recent Studies (post-2010) (daidzein)
6,5207305,2511,885136753

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)daidzein (IC50)
rac GTPase-activating protein 1 isoform aHomo sapiens (human)91.26
Estrogen receptorHomo sapiens (human)2.97
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)9
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)7.3
TransporterRattus norvegicus (Norway rat)0.45
Estrogen receptor betaHomo sapiens (human)1.6568

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdel-Hamid, NM; El-Shishtawy, MM; Eldomany, RA; Nawaya, RA; Zakaria, S1

Other Studies

1 other study(ies) available for sorafenib and daidzein

ArticleYear
Daidzein and Chicory Extract Arrest the Cell Cycle
    Recent patents on anti-cancer drug discovery, 2022, Volume: 18, Issue:2

    Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Checkpoints; Cell Proliferation; Cichorium intybus; Cyclin A; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Gene Expression; Humans; Ki-67 Antigen; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rats; Sorafenib

2022